Search research articles
Contact Us
Filters
Showing results (31-40 of 148) with videos related to
Page
of 15
Sort By:
American Journal of Clinical Oncology
|
June 1, 2004
Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer
Jean Philipe Spano, Thierry Bouillet, Catherine Boaziz, et al.
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
Retina (Philadelphia, Pa.)
|
March 22, 2013
Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?
Nathalie Cassoux, Sylvia Cayette, Corine Plancher, et al.
Nature Reviews. Clinical Oncology
|
January 4, 2023
Advances in the clinical management of uveal melanoma
Richard D Carvajal, Joseph J Sacco, Martine J Jager, et al.
American Journal of Ophthalmology
|
June 15, 2016
Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group
Tero T Kivelä, Sophie Piperno-Neumann, Laurence Desjardins, et al.
Cancer Discovery
|
July 18, 2013
SF3B1 mutations are associated with alternative splicing in uveal melanoma
Simon J Furney, Malin Pedersen, David Gentien, et al.
Molecular Oncology
|
July 5, 2014
Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
Nabil Amirouchene-Angelozzi, Fariba Nemati, David Gentien, et al.
Sarcoma
|
December 11, 2012
Bone sarcomas: from biology to targeted therapies
Nathalie Gaspar, Angela Di Giannatale, Birgit Geoerger, et al.
International Journal of Cancer
|
August 13, 2013
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
François-Clément Bidard, Jordan Madic, Pascale Mariani, et al.
AJR. American Journal of Roentgenology
|
September 29, 2020
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group
Amandine Crombé, Michèle Kind, Isabelle Ray-Coquard, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 148) with videos related to
Sort By:
Page
of 15
American Journal of Clinical Oncology
|
June 1, 2004
Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer
Jean Philipe Spano, Thierry Bouillet, Catherine Boaziz, et al.
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
Retina (Philadelphia, Pa.)
|
March 22, 2013
Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?
Nathalie Cassoux, Sylvia Cayette, Corine Plancher, et al.
Nature Reviews. Clinical Oncology
|
January 4, 2023
Advances in the clinical management of uveal melanoma
Richard D Carvajal, Joseph J Sacco, Martine J Jager, et al.
American Journal of Ophthalmology
|
June 15, 2016
Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group
Tero T Kivelä, Sophie Piperno-Neumann, Laurence Desjardins, et al.
Cancer Discovery
|
July 18, 2013
SF3B1 mutations are associated with alternative splicing in uveal melanoma
Simon J Furney, Malin Pedersen, David Gentien, et al.
Molecular Oncology
|
July 5, 2014
Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
Nabil Amirouchene-Angelozzi, Fariba Nemati, David Gentien, et al.
Sarcoma
|
December 11, 2012
Bone sarcomas: from biology to targeted therapies
Nathalie Gaspar, Angela Di Giannatale, Birgit Geoerger, et al.
International Journal of Cancer
|
August 13, 2013
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
François-Clément Bidard, Jordan Madic, Pascale Mariani, et al.
AJR. American Journal of Roentgenology
|
September 29, 2020
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group
Amandine Crombé, Michèle Kind, Isabelle Ray-Coquard, et al.
Page
of 15